Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer at Stages IB to IIIC of Any Molecular Subtype.

NCT07465497 is registered in ClinicalTrials.gov with Instituto Jalisciense de Cancerologia as lead sponsor.

NCT NCT07465497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07465497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer at Stages IB to IIIC of Any Molecular Subtype.
Lead sponsor
Instituto Jalisciense de Cancerologia
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 27, 2026
Completion date
February 28, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemobrain, inflammatory disease